Ep. 214 Ken Shreve: Improving Portfolio Health With Medical Stocks
Investing With IBD
Dexcom's Stocks in the Diabetes Group
Dexcom is still hanging in there and fighting a, fighting a good fight. ITCI is kind of testing its 10-day moving average but it's forming an awkward looking consolidation on the weekly chart. And intracellular is another, uh, uh, non profitable biotech, but you've got triple digit revenue growth.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
